According to Data Bridge Market Research new Market report “Asia-Pacific APAC Injectable Drug Delivery Market By Type (Devices (Conventional Injection Devices, Self Injection Devices), Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Phillipines, and Rest of APAC) – Industry Trends and Forecast to 2024”, is estimated at USD 154.0 billion in 2016 and is projected to reach USD 143.1 billion by 2024, at a CAGR of 12.4% during the forecast period from 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Access Report: http://databridgemarketresearch.com/reports/asia-pacific-injectable-drug-delivery-market/
Based on geography the asia-pacific (apac) injectable drug delivery market is segmented into 11 major countries such as Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Phillipines, and Rest of APAC.
The market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.
Some of the major players operating in this market are Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, and Teva Pharmaceuticals Industries Ltd.
Browse Related Reports:
Global Injectable Drug Delivery Market, By Type (Devices (Conventional Injection Devices, Self Injection Devices), Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/
North America Injectable Drug Delivery Market By Type (Devices (Conventional Injection Devices, Self Injection Devices),Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/north-america-injectable-drug-delivery-market/
Global Injectable Drug Delivery Market - Industry Trends and Forecast to 2025
North America Injectable Drug Delivery Market – Industry Trends and Forecast to 2027
Europe Injectable Drug Delivery Market – Industry Trends and Forecast to 2027
Asia-Pacific Injectable Drug Delivery Market – Industry Trends and Forecast to 2027
Global Injectable drug delivery market is poised to reach USD 797.2 billion by 2022
Injectable Drug Delivery Market Rising at 12.4% CAGR Due to Surging Prevalence of Chronic Diseases
North America Injectable Drug Delivery Market is Poised to Grow at 11.0% to 2024
Europe Injectable Drug Delivery Market Poised to Grow At 11.9% till 2024
Global Injectable Drug Delivery Market is Expected to Grow by CAGR 11.5% In The Forecast Period 2017 To 2024
North America Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024
Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025
Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025